Overview: Dorothy Mary Crowfoot Hodgkin (12 May 1910 – 29 July 1994) was a British chemist whose work established modern protein crystallography. She used X‑ray diffraction to determine three‑dimensional arrangements of atoms in complex organic and biological molecules, transforming chemistry, biochemistry and medicine. Hodgkin received the Nobel Prize in Chemistry in 1964 for these determinations and was honoured as a Fellow of the Royal Society and with the Order of Merit.

Major contributions

Hodgkin developed experimental and interpretive methods that made it possible to translate X‑ray diffraction patterns into electron density maps and detailed molecular models. Her laboratory resolved several landmark structures whose atomic detail explained chemical behaviour and biological function:

  • Penicillin — one of the earliest antibiotic structures to be clarified, aiding understanding of how the drug works.
  • Vitamin B12 — a complex corrin ring whose elucidation explained aspects of its reactivity and role in biology.
  • Insulin — the protein hormone whose structure informed how insulin functions and helped later therapeutic production.

Methods and scientific impact

Hodgkin combined careful crystallization, precise X‑ray measurements and physical model building to interpret electron density. She and her colleagues applied heavy‑atom techniques and comparative approaches, such as multiple isomorphous replacement, to overcome the crystallographic phase problem. These practices laid the groundwork for later advances: synchrotron radiation, cryo‑methods and computational refinement all build on principles she helped establish. Structural knowledge of biomolecules now underpins rational drug design, enzyme engineering and understanding of disease mechanisms.

Career, recognition and legacy

Hodgkin spent much of her career at the University of Oxford, where she led a generation of researchers in structural science and mentored many students. In addition to the Nobel Prize she was a Fellow of the Royal Society and received national honours. She remains one of the most influential figures in molecular structural studies; her work underpins modern structural biology and the development of biopharmaceuticals.

For a concise biography and further reading see Dorothy Hodgkin. Her legacy continues in the techniques, institutions and practical applications that grew from the structural knowledge she helped create.